(19)
(11) EP 1 158 999 A2

(12)

(88) Date of publication A3:
18.01.2001

(43) Date of publication:
05.12.2001 Bulletin 2001/49

(21) Application number: 00921362.0

(22) Date of filing: 02.03.2000
(51) International Patent Classification (IPC)7A61K 38/20, A61K 39/395, A61P 37/00
// C12N5:10,(A61K38/20, 35:12),(A61K39/395, 35:12),(A61K38/20, 35:12), A61K38:13,(A61K38/20, 35:12, 31:445),(A61K38/20, 35:12, 31:57)
(86) International application number:
PCT/US0005/647
(87) International publication number:
WO 0051/630 (08.09.2000 Gazette 2000/36)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 05.03.1999 US 263011

(71) Applicant: DIACRIN, INC.
Charlestown, MA 02129 (US)

(72) Inventor:
  • EDGE, Albert
    Cambridge, MA 02138 (US)

(74) Representative: Lock, Graham James et al
Fry Heath & Spence,The Old College,53 High Street
Horley,Surrey RH6 7BN
Horley,Surrey RH6 7BN (GB)

   


(54) METHODS FOR IMPROVING GRAFT ACCEPTANCE IN A RECIPIENT BY ADMINISTRATION OF A CYTOKINE PROFILE ALTERING AGENT